Indications of a geographic muddle
Are Geographical Indications safeguarding the interests of growers and artisans?
A patent triumph of public interest
New flexibilities make public interest safeguards integral to drug patent rights
Rethinking IP think tank
Government sidelines its committee of experts to set up new panel to review India's intellectual property rights policy
Activists demand compulsory licence for another life-saving cancer drug
Appellate board's order upholding Natco's CL for sorafenib tosylate may pave way for manufacture of generic version of other patented drugs
Gopal Subramaniam, Rohinton Nariman swap places in Novartis patent case
Will take on each other in the patent case of anti-cancer drug Glivec filed by Novartis
Will appellate body uphold grant of compulsory licence to cancer drug?
Hearing on Bayer's appeal against manufacture of generic version of Nexavar to conclude this week